Enhance MD

1. 3. The availability answer lists 40 states plus DC, subject to product availability and eligibility. Its separate statement about licensure in all 50 states does not establish nationwide service. A medical-provider video visit determines eligibility; the site names US-licensed physicians and nurse practitioners. Source: https://enhance.md/faq.
2. 4. The terms require cancellation before the next billing cycle, while the FAQ permits pausing or canceling at any time and describes 28-day renewal and refill billing. Selected treatment cards describe longer billing intervals. Full checkout payment terms are not established by these public summaries. Initial onboarding ineligibility qualifies for a full initial-payment refund; the 5–10 business-day processing estimate is not an extra refund promise. Prescription returns are not accepted, and quality concerns can be raised with the provider. Sources: https://enhance.md/terms-of-service, https://enhance.md/faq and https://enhance.md/shipping-returns.
3. 5. GLP-1 Core advertises 12-month selection $212/mo with billing every 48 weeks; 6-month selection $224/mo with billing every 24 weeks; 3-month selection $237/mo with billing every 12 weeks; 1-month selection $249/mo with billing every 4 weeks. The advertised rate is not a verified full selected invoice or calendar-month bill. First-order discount language does not establish an amount collected. Source: https://enhance.md/product/core-semaglutide.
4. 6. GLP-1 Core is explicitly identified as a compounded semaglutide injection. Its named-page inclusions are four weeks of medication, ongoing care, six-monthly metabolic lab testing, essential supplies, wellness coaching and platform access. The exact injection device is not established by those descriptions or the marketing vial image. Source: https://enhance.md/product/core-semaglutide.
5. 7. GLP-1 Advanced advertises 12-month selection $280/mo with billing every 48 weeks; 6-month selection $296/mo with billing every 24 weeks; 3-month selection $313/mo with billing every 12 weeks; 1-month selection $329/mo with billing every 4 weeks. The advertised rate is not a verified full selected invoice or calendar-month bill. First-order discount language does not establish an amount collected. Source: https://enhance.md/product/advanced-tirzepatide.
6. 8. Microdosing Tirzepatide advertises 12-month selection $169/mo with billing every 48 weeks; 6-month selection $179/mo with billing every 24 weeks; 3-month selection $189/mo with billing every 12 weeks. The advertised rate is not a verified full selected invoice or calendar-month bill. First-order discount language does not establish an amount collected. Source: https://enhance.md/product/microdosing-tirzepatide.
7. 9. GLP-1 Advanced is a compounded tirzepatide injection; its inclusions name syringes and alcohol pads, but an assigned pen or vial is not established. Microdosing Tirzepatide is a separately marketed lower-dose injection variant with delivery every 12 weeks and three visible priced selections. It shares the recorded tirzepatide/injection category here; its dose, supply and price terms must remain separate from Advanced. No priced one-month microdose option is visible. Sources: https://enhance.md/product/advanced-tirzepatide and https://enhance.md/product/microdosing-tirzepatide.
8. 10. GLP-1 Elite is a combined semaglutide-and-tirzepatide program, distinct from Advanced tirzepatide. Historical Elite figures within this record do not establish a current standalone tirzepatide price. Current combined-program pricing belongs to its separate category and source conditions. Source: https://enhance.md/product/elite-tirzepatide-and-semaglutide.
9. 11. GLP-1 Elite advertises 12-month selection $322/mo with billing every 48 weeks; 6-month selection $341/mo with billing every 24 weeks; 3-month selection $360/mo with billing every 12 weeks; 1-month selection $379/mo with billing every 4 weeks. The advertised rate is not a verified full selected invoice or calendar-month bill. First-order discount language does not establish an amount collected. Source: https://enhance.md/product/elite-tirzepatide-and-semaglutide.
10. 12. GLP-1 Elite is described as a compounded injection program combining semaglutide and tirzepatide. The named inclusion answer says it includes four weeks of Elite medication formulated with both ingredients, ongoing care, six-monthly lab testing, essential supplies, coaching and platform access. A single coformulated dosage unit, assigned vial or pen, exact strengths and concurrent dosing regimen are not established. The company’s comparative clinical marketing is not independent evidence of additional benefit or safety. Source: https://enhance.md/product/elite-tirzepatide-and-semaglutide.

September 2026

1. 13. On where it operates, the company's own wording is: “We are pleased to inform you that Enhance.MD is licensed in all 50 states. However, based on product availability, we will be launching in select states which currently include:” No list of served states appears, so none is recorded above.

August 2026

1. 14. Enhance MD prices its three GLP-1 tiers with a lower first-month rate that roughly doubles from month two on. The cards read "GLP-1 Core semaglutide — Starting at $112 first month — $212 /month (All doses)"; "GLP-1 Advanced tirzepatide — Starting at $180 first month — $280 /month (All Doses)"; and "GLP-1 Elite semaglutide + tirzepatide — Starting at $222 first month — $322 /month (All Doses)". Each tier lists "4 Weeks of Medication", "Ongoing Provider Care & Support" and "Metabolic Lab Testing Every 6 Months".
2. 15. The discount claim, quoted twice from the same page the same day: the site-wide banner, "Begin GLP-1 weight loss with up to $150 off your first order. Get started today", and the hero, "Labor Day Sale: Our Best Offer of the Year. Save up to $150 on your first order."
3. 16. No product on enhance.md is $150 off. Five cards carried a price on August 31, 2026: GLP-1 Core, GLP-1 Advanced, GLP-1 Elite, NAD+ Therapy and Microdosing Tirzepatide. Three show a first-month figure — $112 against $212, $180 against $280 and $222 against $322 — and each of those gaps is exactly $100. The other two, NAD+ at “$169 /month” and Microdosing Tirzepatide at “$169 /month”, carry no first-month figure at all; their first-month slots are empty in the page's own markup, so a reader sees no discount rather than a broken one.
4. 17. The four-week arithmetic, shown. Enhance MD publishes "4 Weeks of Medication" and "$212 /month" on the same card. Thirteen four-week supplies is 364 days, so a year is 13 × $212 = $2,756. Twelve payments of $212 would be $2,544. The figure is our multiplication of theirs.
5. 18. Enhance.MD’s microdose card gives a monthly price and a quarterly shipment in the same block, and never says which one you are billed on: "Microdosing Tirzepatide lower-dose tirzepatide — Starting at $169 /month (1mg/week) — Dual GLP-1 + GIP signaling at lower, capped doses — Medication shipped every 12 weeks — Ongoing Provider Care & Support."
6. 19. Enhance.MD is a management company, not the entity that treats patients. Its own footer states: "Enhance.MD LLC is a patient management platform that provides administrative and operational support to physicians and practitioners employed by Enhance Wellness PC and iThriveMD PC, who deliver care through a telehealth platform. Enhance.MD LLC does not provide medical or pharmacy services, employ healthcare providers, or influence clinical decision-making. Payment does not guarantee the prescribing or dispensing of medication." The registered address given is "16192 Coastal Highway, Lewes, Delaware 19958".
7. 20. Enhance.MD backs its pricing with two written guarantees: "Same price at every dose — Our 'same price at every dose' guarantee means you pay the same flat rate no matter how much your dose increases—no hidden fees or price jumps" and "100% Money-back guarantee — If at any point during the onboarding process your provider finds you ineligible for medication, Enhance.MD will provide a refund."